Home

Emcure Pharmaceuticals Ltd Quarterly Result

Image

Emcure Pharmaceuticals Ltd

NSE: EMCURE

Net Profit - Last Quarter

₹ 201.55 Cr.

Last updated on: Jan 15, 2025

Key Highlights

  • The revenue of Emcure Pharmaceuticals Ltd for the Sep '24 is ₹ 2037 crore as compare to the Jun '24 revenue of ₹ 1838 crore. This represent the growth of 10.826838%.
  • The ebitda of Emcure Pharmaceuticals Ltd for the Sep '24 is ₹ 416.53 crore as compare to the Jun '24 ebitda of ₹ 359.76 crore. This represent the growth of 15.779962%.
  • The net profit of Emcure Pharmaceuticals Ltd for the Sep '24 is ₹ 201.55 crore as compare to the Jun '24 net profit of ₹ 152.59 crore. This represent the growth of 32.085987%.

Results Analysis

Market Price of Emcure Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Emcure Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 20251363
14 Jan 20251351.45
13 Jan 20251315.7
10 Jan 20251355.35
09 Jan 20251433.1
08 Jan 20251450.05
07 Jan 20251418.15
06 Jan 20251425.3
03 Jan 20251463.45
02 Jan 20251478.35

Historical Revenue of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Emcure Pharmaceuticals Ltd News Hub

Emcure Pharmaceuticals receives upgrade in credit ratings from CRISIL

Emcure Pharmaceuticals has received upgrade in credit ratings from CRISIL for bank facilities of Rs

Read more

13 Aug 2024

Emcure Pharmaceuticals receives upgrade in credit ratings for bank facilities

Emcure Pharmaceuticals announced that CARE Ratings has upgraded the credit ratings assigned to bank

Read more

13 Aug 2024

Emcure Pharmaceuticals consolidated net profit rises 10.48% in the June 2024 quarter

Net profit of Emcure Pharmaceuticals rose 10.48% to Rs 144.08 crore in the quarter ended June 2024 a

Read more

14 Aug 2024

Emcure Pharmaceuticals to declare Quarterly Result

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 202

Read more

10 Aug 2024

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Emcure Pharmaceuticals Ltd

What key financial metrics are included in Emcure Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Emcure Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Emcure Pharmaceuticals Ltd announce its quarterly results?

Emcure Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Emcure Pharmaceuticals Ltd's quarterly performance impact its stock price?

Emcure Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Emcure Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Emcure Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Emcure Pharmaceuticals Ltd's quarterly results?

Yes, Emcure Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions